康诺亚 TSLP 单抗启动新 III 期,石药拥有权益

丁香园 Insight 数据库
Feb 05

药物临床试验登记与信息公示平台官网显示,康诺亚登记了一项评价 CM326 重组人源化单克隆抗体注射液治疗慢性鼻窦炎伴鼻息肉患者的有效性、安全性的多中心、随机、双盲、安慰剂平行对照的 III 期临床试验(登记号:CTR20260394)。来源:药物临床试验登记与信息公示平台官网该研究计划纳入212 名受试者,随机分组接受 CM326 和安慰剂治疗,每 4 周给药一次,双盲治疗期内共给药 6 次,开放...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10